Scientists provided important evidence that kaempferol targeting RSKs might be a strategy to reduce the oxaliplatin-resistant colon cancer cells.
[Archives of Pharmacal Research]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.